Links Found Between Leaders of Medical Associations, Industry
Most leaders have ties to industry; considerable variation seen among 10 medical associations in U.S.
CV Toxicity Tied to Azithromycin and/or Hydroxychloroquine
Risk increased for prolonged QT and/or ventricular tachycardia, including torsades de pointes
Only One in Four U.S. Hospitals With ICUs Have Tele-ICU Services
Wide regional variation seen for availability of telehealth outpatient visits, tele-ICU services
Surgery Not Superior for Closed Displaced Humeral Shaft Fractures
Findings based on 12-month functional outcomes for surgery compared with functional bracing
African-Americans More Likely to Be Hospitalized With COVID-19
Odds of hospitalization increased 2.7-fold versus non-Hispanic whites after adjustment for age, sex, comorbidity
Placental Injury Seen in Pregnant Women With SARS-CoV-2
Higher rates of decidual arteriopathy, other maternal vascular malperfusion features observed
Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise
ELISA antibodies and neutralizing antibodies increased at day 14, peaked at day 28
Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research
Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers
